Diligent Investors’s Boston Scientific BSX Stock Holding History

Diligent Investors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,334	Closed	-$235K	–	340
2025 Q1	$235K	Hold	2,334	–	–	0.06%	321
2024 Q4	$208K	Buy	+2,334	New	+$205K	0.05%	348
2018 Q4	–	Sell	-6,494	Closed	-$250K	–	191
2018 Q3	$250K	Sell	6,494 -300	-4%	-$10.5K	0.14%	166
2018 Q2	$222K	Buy	+6,794	New	+$205K	0.14%	162
2018 Q1	–	Sell	-9,494	Closed	-$235K	–	203
2017 Q4	$235K	Sell	9,494 -670	-7%	-$18.5K	0.15%	163
2017 Q3	$296K	Sell	10,164 -1,000	-9%	-$27.6K	0.22%	126
2017 Q2	$309K	Hold	11,164	–	–	0.22%	119
2017 Q1	$28K	Hold	11,164	–	–	0.02%	162
2016 Q4	$241K	Hold	11,164	–	–	0.19%	133
2016 Q3	$266K	Sell	11,164 -470	-4%	-$11.2K	0.22%	120
2016 Q2	$272K	Sell	11,634 -1,000	-8%	-$21.6K	0.26%	109
2016 Q1	$238K	Sell	12,634 -388	-3%	-$6.82K	0.26%	113
2015 Q4	$240K	Hold	13,022	–	–	0.27%	108
2015 Q3	$217K	Sell	13,022 -300	-2%	-$5.13K	0.23%	125
2015 Q2	$238K	Hold	13,322	–	–	0.25%	118
2015 Q1	$234K	Hold	13,322	–	–	0.24%	120
2014 Q4	$196K	Buy	+13,322	New	+$170K	0.2%	139

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Diligent Investors's BSX Position: Q2 2025 in Review

Diligent Investors sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 2,334 shares — an estimated $235K sold.

Diligent Investors first reported a position in BSX in Q4 2014 and held it in 17 quarters. The position peaked at $309K in Q2 2017. 1,693 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

Diligent Investors reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
Diligent Investors sold 2,334 Boston Scientific shares in Q2 2025, an estimated $235K.
Diligent Investors first reported a position in Boston Scientific in Q4 2014 and held it in 17 quarters.
Diligent Investors's Boston Scientific position peaked at $309K in Q2 2017.
1,693 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Diligent Investors's 13F filing for Q2 2025, filed 22 Jul 2025.